Skip to content
healthcare.dev

Quillivant XR

NDC 24478-323, methylphenidate hydrochloride, suspension, extended release, from NextWave Pharmaceuticals, Inc.

Product NDC
24478-323
Status
Listed
Labeler
NextWave Pharmaceuticals, Inc
Dosage form
SUSPENSION, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA202100
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/24478-323 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHYLPHENIDATE HYDROCHLORIDE750 mg/150mL

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
24478-323-05244780323051 BOTTLE in 1 CARTON (24478-323-05) / 150 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c2dc2109-44a6-4797-b04e-18761dd9d45a
  • NADAC price for package 24478032305

    GET /v1/drugs/nadac/24478032305

Use it

Look up 24478-323 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/24478-323 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 24478-323. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.